Literature DB >> 32827029

NOTCH2NLC CGG Repeats Are Not Expanded and Skin Biopsy Was Negative in an Infantile Patient With Neuronal Intranuclear Inclusion Disease.

Ivana Jedlickova1, Anna Pristoupilova1, Helena Hulkova1,2, Alena Vrbacka1, Viktor Stranecky1, Eva Hruba1, Pavel Jesina1, Tomas Honzik1, Ivan Hrdlicka3, Jiri Fremuth4, Kristyna Pivovarcikova5, Ibrahim Bitar6, Radoslav Matej2,7, Stanislav Kmoch1, Jakub Sikora1,2.   

Abstract

Neuronal intranuclear inclusion disease (NIID) is a progressive neurodegenerative disorder categorized into 3 phenotypic variants: infantile, juvenile, and adult. Four recent reports have linked NIID to CGG expansions in the NOTCH2NLC gene in adult NIID (aNIID) and several juvenile patients. Infantile NIID (iNIID) is an extremely rare neuropediatric condition. We present a 7-year-old male patient with severe progressive neurodegenerative disease that included cerebellar symptoms with cerebellar atrophy on brain MRI, psychomotor developmental regression, pseudobulbar syndrome, and polyneuropathy. The diagnosis of iNIID was established through a postmortem neuropathology work-up. We performed long-read sequencing of the critical NOTCH2NLC repeat motif and found no expansion in the patient. We also re-evaluated an antemortem skin biopsy that was collected when the patient was 2 years and 8 months old and did not identify the intranuclear inclusions. In our report, we highlight that the 2 methods (skin biopsy and CGG expansion testing in NOTCH2NLC) used to identify aNIID patients may provide negative results in iNIID patients.
© 2020 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  zzm321990 NOTCH2NLCzzm321990 ; Cerebellum; Infantile neuronal intranuclear inclusion disease; Neuropathology; Trinucleotide repeat expansions

Year:  2020        PMID: 32827029     DOI: 10.1093/jnen/nlaa070

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  2 in total

1.  Hornerin deposits in neuronal intranuclear inclusion disease: direct identification of proteins with compositionally biased regions in inclusions.

Authors:  Hongsun Park; Tomoyuki Yamanaka; Yumiko Toyama; Atsushi Fujita; Hiroshi Doi; Takashi Nirasawa; Shigeo Murayama; Naomichi Matsumoto; Tomomi Shimogori; Masaya Ikegawa; Matti J Haltia; Nobuyuki Nukina
Journal:  Acta Neuropathol Commun       Date:  2022-03-04       Impact factor: 7.801

2.  Reply to: No evidence supports genetic heterogeneity of neuronal intranuclear inclusion disease.

Authors:  Zhongbo Chen; Mina Ryten; Henry Houlden
Journal:  Ann Clin Transl Neurol       Date:  2020-10-30       Impact factor: 5.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.